Changchun GeneScience Pharmaceutical
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (68)
A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets
Started: 9/12/2025
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
Started: 8/20/2025
Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma
Started: 1/10/2026
Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.
Started: 8/21/2024
The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart.
Started: 7/12/2022
Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase
Started: 5/1/2025
Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis
Started: 6/1/2025
Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma After Surgery.
Started: 1/1/2025
Safety & Efffficacy of Genakumab in Patients With Frequent Flares
Started: 1/11/2023
To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference
Started: 3/24/2023
To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection
Started: 9/20/2024
Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation
Started: 5/1/2008
A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics
Started: 11/11/2025
A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain
Started: 5/26/2025
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
Started: 12/30/2023
Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD
Started: 2/1/2026
Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women.
Started: 10/14/2024
A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)
Started: 12/19/2025
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
Started: 5/12/2017
Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature
Started: 4/23/2015
A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)
Started: 7/20/2023
Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare
Started: 7/21/2023
A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence
Started: 1/6/2022
A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA
Started: 12/1/2009
A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.
Started: 6/18/2026
A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)
Started: 6/9/2025
A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.
Started: 3/16/2026
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy Adult Participants
Started: 4/20/2026
A Study（Phase I）of GS3-007a Dry Suspension in Healthy Chinese Adults
Started: 1/7/2026
A Study of GensSci098 in Subjects With Graves' Disease
Started: 11/21/2025
A Study of GenSci098 in Subjects With Active Thyroid Eye Disease
Started: 9/24/2024
GenSci143 in Participants With Advanced Solid Tumors
Started: 12/20/2025
A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation
Started: 6/10/2025
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid Tumors
Started: 12/10/2025
Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.
Started: 8/1/2025
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors
Started: 1/8/2025
A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants
Started: 4/1/2026
To Evaluate the Impact of Smoking on PK After Single-dose Oral Administration of GS1-144 Tablets .
Started: 5/27/2026
Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Started: 4/1/2021
GS1-144 in Participants With Hepatic Impairment and Healthy Female
Started: 4/20/2026
A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)
Started: 3/6/2026
A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)
Started: 3/6/2026
GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors.
Started: 3/14/2026
A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults.
Started: 2/20/2025
A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese Women
Started: 12/1/2025
A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)
Started: 12/1/2025
A Study on Bioequivalence of Cabergoline Tablets in Human Body
Started: 6/30/2025
Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
Started: 9/29/2025
A Bioavailability Study of GS1-144 Tablets in Healthy Postmenopausal Women
Started: 4/30/2025
A Bioequivalence Study of Two Different PEG-rhGH Preparations
Started: 2/10/2025
A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Dose Escalation of GS1-144 Tablets and the Effects of Food on the Pharmacokinetics of GS1-144 in a Chinese Population
Started: 1/3/2024
A Bioavailability Study of Two Different PEG-rhGH Preparations.
Started: 5/8/2024
A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations
Started: 11/6/2023
A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations
Started: 10/31/2023
Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults
Started: 3/6/2023
Clinical Study of Genakumab for Injection in Patients With Acute Gout
Started: 5/22/2021
A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations
Started: 5/1/2025
A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers
Started: 2/27/2024
A Bioequivalence Study of Two Different Dosage Form of Genakumab
Started: 6/24/2024
The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing Site
Started: 9/19/2023
A Bioequivalence Study of Two Different PEG-rhGH Preparations.
Started: 4/9/2024
To Evaluate the Safety and Tolerability of Multiple Doses of GS3-007a Oral Solution in Healthy Subjects.
Started: 6/19/2023
Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma
Started: 4/12/2021
Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children
Started: 3/1/2010
A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia
Started: 9/25/2025
Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn
Started: 11/1/2010